Paper8913475
Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin.
Düzgüneş N and 4 others. Antimicrob Agents Chemother, 1996. Cited by 35 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin. Papers, record 8913475. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8913475
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Infective Agents | Major topic |
| Fluoroquinolones | Major topic |
| Mycobacterium avium-intracellulare Infection | Major topic |
| Quinolones | Major topic |
| Animals | |
| Cell Line | |
| Cell Survival | |
| Humans | |
| Indicators and Reagents | |
| Liposomes | |
| Macrophages | |
| Mice | |
| Mice, Inbred Strains |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AI-33833 | NIAID NIH HHS | United States | R01AI033833 | PubMed and NIH |
Source NIH RePORTER
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,692,845 | Interaction of liposomes with Kupffer cells in vitro. | Exp Cell Res | 1984 | https://conductscience.org/library/papers/6692845 | PubMed |
| 2 | 3,880,852 | Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature. | Medicine (Baltimore) | 1985 | https://conductscience.org/library/papers/3880852 | PubMed |
| 3 | 2,996,410 | Treatment of infections in patients with the acquired immunodeficiency syndrome. | Ann Intern Med | 1985 | https://conductscience.org/library/papers/2996410 | PubMed |
| 4 | 3,729,201 | Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. | Ann Intern Med | 1986 | https://conductscience.org/library/papers/3729201 | PubMed |
| 5 | 3,794,396 | Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. | J Infect Dis | 1987 | https://conductscience.org/library/papers/3794396 | PubMed |
| 6 | 3,541,122 | Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. | Rev Infect Dis | 1986 | https://conductscience.org/library/papers/3541122 | PubMed |
| 7 | 3,813,519 | Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3813519 | PubMed |
| 8 | 3,196,002 | Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3196002 | PubMed |
| 9 | 2,912,355 | The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). | Am Rev Respir Dis | 1989 | https://conductscience.org/library/papers/2912355 | PubMed |
| 10 | 2,926,169 | Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS. | J Infect Dis | 1989 | https://conductscience.org/library/papers/2926169 | PubMed |
| 11 | 2,654,113 | Fungal and mycobacterial infections in patients infected with the human immunodeficiency virus. | J Antimicrob Chemother | 1989 | https://conductscience.org/library/papers/2654113 | PubMed |
| 12 | 2,345,306 | Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides. | J Infect Dis | 1990 | https://conductscience.org/library/papers/2345306 | PubMed |
| 13 | 2,162,207 | Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay. | Biochim Biophys Acta | 1990 | https://conductscience.org/library/papers/2162207 | PubMed |
| 14 | 2,393,294 | Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2393294 | PubMed |
| 15 | 2,238,129 | Differential effects of free and liposome encapsulated amikacin on the survival of Mycobacterium avium complex in mouse peritoneal macrophages. | Tubercle | 1990 | https://conductscience.org/library/papers/2238129 | PubMed |
| 16 | 2,017,230 | Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. | N Engl J Med | 1991 | https://conductscience.org/library/papers/2017230 | PubMed |
| 17 | 2,088,204 | In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2088204 | PubMed |
| 18 | 2,056,201 | Treatment of Mycobacterium avium-intracellulare complex infection in beige mice with free and liposome-encapsulated streptomycin: role of liposome type and duration of treatment. | J Infect Dis | 1991 | https://conductscience.org/library/papers/2056201 | PubMed |
| 19 | 1,892,297 | Therapeutic efficacy of liposome-encapsulated kanamycin against Mycobacterium intracellulare infection induced in mice. | Am Rev Respir Dis | 1991 | https://conductscience.org/library/papers/1892297 | PubMed |
| 20 | 1,656,860 | Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1656860 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,810,644 | Liposome-Based Antibacterial Delivery: An Emergent Approach to Combat Bacterial Infections. | ACS Omega | 2023 | https://conductscience.org/library/papers/37810644 | PubMed |
| 30,714,523 | Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control. | Curr Drug Deliv | 2019 | https://conductscience.org/library/papers/30714523 | PubMed |
| 28,210,505 | Nanotechnology-Based Approach in Tuberculosis Treatment. | Tuberc Res Treat | 2017 | https://conductscience.org/library/papers/28210505 | PubMed |
| 16,847,556 | A comparison of the in vitro antimicrobial activity of liposomes containing meropenem and gentamicin. | Cell Mol Biol Lett | 2006 | https://conductscience.org/library/papers/16847556 | PubMed |
| 11,302,815 | Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11302815 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8913475
GET https://conductscience.org/api/papers/v1/8913475/references?page=2